Inventor · disambiguated record
Jean-Philippe Bürckert
Also filed as: BURCKERT JEAN-PHILIPPE · BÜRCKERT JEAN-PHILIPPE
6 granted patents·4 pending applications·49 citations·filing 2020–2025
81Inventor score
Top patents by PatentIndex Score
10 records- 0193US11028167B1Anti-SARS-Cov-2 antibodies derived from 3bgfCENTIVAX INC·Filed 2020·Granted Jun 8, 2021·11 cites·21 claims
- 0293US11021531B1Anti-SARS-Cov-2 antibodies derived from 2GHWCENTIVAX INC·Filed 2020·Granted Jun 1, 2021·17 cites·16 claims
- 0392US11053304B1Anti-SARS-Cov-2 antibodies derived from 6nb6CENTIVAX INC·Filed 2020·Granted Jul 6, 2021·10 cites·21 claims
- 0492US11028150B1Anti-SARS-CoV-2 antibodies derived from 2DD8CENTIVAX INC·Filed 2020·Granted Jun 8, 2021·7 cites·21 claims
- 0591US11034762B1Anti-SARS-Cov-2 antibodies derived from CR3022CENTIVAX INC·Filed 2020·Granted Jun 15, 2021·4 cites·13 claims
- 0675US12291579B2Anti-phosphocholine antibodies and methods of use thereofOXITOPE PHARMA B V·Filed 2024·Granted May 6, 2025·0 cites·20 claims
- 0761US2024270825A1Anti-sars-cov-2 antibodies derived from cr3022CENTIVAX INC·Filed 2023·Application pending·0 cites
- 0858US2025215104A1Novel soluble urokinase plasminogen activator receptor (supar) binding molecules and uses thereofWALDEN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0956US2025320312A1Anti-phosphocholine antibodies and methods of use thereofOXITOPE PHARMA B V·Filed 2025·Application pending·0 cites
- 1049US2022088175A1Optimized vaccine compositions and methods for making the sameCENTIVAX INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean-Philippe Bürckert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →